Home  |  Corporate Info  |  R & D  |  Products  |  Investor Relations  |  For the Patient  |  Careers at Hemispherx  


   

Position:        Manufacturing Technician

Location:        New Brunswick, NJ

Job Description and Responsibilities: 
  • Perform unit operations in the manufacture of blood derived alpha interferon and a synthetic RNA species. 
  • Operations in the manufacture of the interferon include but are not limited to cell isolation and culture, solution formulation, sterile component preparation, cell harvesting, bulk liquid concentration, preparative chromatography and related operations. 
  • Operations in the manufacture of the RNA include but are not limited to RNA synthesis, extraction, precipitation, diafiltration and freeze-drying. 
  • Both processes require compliance to cGMPs.

Job Requirements:
  • A minimum of 2 years experience in a cGMP manufacturing environment or a BS in life science, chemistry, or related field is required. 
  • Experience in at least some of the operations listed above would be preferable.
  • Experience with bio-hazardous materials and/or hazardous solvents is important.
  • Must be willing to work in a team environment.
     

Please forward resumes:

  • Via US Mail:
    Hemispherx Biopharma, Inc.
    Director of Human Resources   
    783 Jersey Avenue
    New Brunswick, NJ  08901

  • Via Facsimile: (732) 249-6895

  • Via E-mail: hr@hemispherx.net.
 
 

 
Information contained on the Hemispherx website other than historical information, should be considered forward-looking and is subject to various risk factors and uncertainties. For instance, the strategies and operations of Hemispherx involve risks of competition, changing market conditions, changes in laws and regulations affecting these industries and numerous other factors discussed on the Hemispherx website and in the Company's filings with the Securities and Exchange Commission. Accordingly, actual results may differ materially from those in any forward-looking statements. Additionally, all the referenced investigational drugs and associated technologies of the company are experimental in nature and as such are not designated safe and effective by a regulatory authority for general use and are legally available only through clinical trials with the referenced disorders. The forward-looking statements represent the Company's judgement as of the date of this website. The Company disclaims, however, any intent or obligation to update these forward-looking statements.